Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 04:00PM ET
2.32
Dollar change
+0.17
Percentage change
7.91
%
Index- P/E- EPS (ttm)-0.85 Insider Own61.47% Shs Outstand8.38M Perf Week63.38%
Market Cap21.39M Forward P/E- EPS next Y-0.95 Insider Trans0.00% Shs Float3.55M Perf Month45.00%
Income-7.24M PEG- EPS next Q-0.20 Inst Own1.69% Short Float0.27% Perf Quarter65.12%
Sales0.32M P/S66.84 EPS this Y53.59% Inst Trans- Short Ratio0.40 Perf Half Y23.40%
Book/sh0.76 P/B3.06 EPS next Y-13.10% ROA-59.69% Short Interest0.01M Perf Year36.47%
Cash/sh0.49 P/C4.74 EPS next 5Y- ROE-73.89% 52W Range0.95 - 2.24 Perf YTD57.77%
Dividend Est.- P/FCF- EPS past 5Y- ROI-87.94% 52W High3.57% Beta3.86
Dividend TTM- Quick Ratio3.06 Sales past 5Y0.00% Gross Margin42.66% 52W Low142.98% ATR (14)0.16
Dividend Ex-Date- Current Ratio3.07 EPS Y/Y TTM45.40% Oper. Margin-2256.55% RSI (14)81.61 Volatility20.36% 7.44%
Employees14 Debt/Eq0.24 Sales Y/Y TTM12989.94% Profit Margin-2251.53% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.18 EPS Q/Q55.19% Payout- Rel Volume2.97 Prev Close2.15
Sales Surprise198.50% EPS Surprise-44.44% Sales Q/Q25855.13% EarningsNov 14 AMC Avg Volume24.05K Price2.32
SMA2043.31% SMA5047.02% SMA20044.07% Trades Volume71,465 Change7.91%
Feb-21-24 08:00AM
Feb-06-24 08:00AM
Jan-30-24 08:00AM
Jan-23-24 08:00AM
Jan-08-24 08:00AM
09:00AM Loading…
Jan-05-24 09:00AM
Dec-05-23 08:00AM
Nov-30-23 08:00AM
Nov-28-23 08:00AM
Nov-15-23 08:00AM
Nov-14-23 04:01PM
Nov-06-23 08:00AM
Oct-10-23 08:00AM
Sep-21-23 09:35AM
Sep-19-23 08:00AM
08:00AM Loading…
Sep-07-23 08:00AM
Aug-14-23 05:03PM
Jul-12-23 08:00AM
Jun-15-23 08:00AM
May-22-23 08:00AM
May-15-23 08:00AM
May-01-23 08:00AM
Apr-25-23 08:00AM
Apr-05-23 08:00AM
Mar-31-23 05:52PM
Mar-28-23 08:00AM
Mar-24-23 08:00AM
Feb-13-23 08:00AM
Jan-24-23 08:00AM
Jan-04-23 08:00AM
11:33AM Loading…
Dec-19-22 11:33AM
Dec-15-22 08:30AM
Dec-01-22 08:00AM
Nov-14-22 07:30AM
Nov-10-22 08:15AM
Nov-08-22 08:00AM
Oct-25-22 09:15AM
Oct-12-22 08:15AM
Sep-28-22 08:15AM
Sep-14-22 08:15AM
Sep-06-22 01:54PM
11:28AM
Sep-01-22 12:32PM
08:15AM
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.